ZBIO logo

Zenas BioPharma, Inc. (ZBIO) Cash From Investing

Annual CFI:

-$30.55M-$30.54M(-179617.65%)
December 31, 2024

Summary

  • As of today, ZBIO annual cash from investing is -$30.55 million, with the most recent change of -$30.54 million (-179617.65%) on December 31, 2024.
  • During the last 3 years, ZBIO annual cash from investing has fallen by -$28.35 million (-1289.99%).
  • ZBIO annual cash from investing is now -179617.65% below its all-time high of -$17.00 thousand, reached on December 31, 2023.

Performance

1-Year Change

-179617.65%

3-Year Change

-1289.99%

5-Year Change

-1289.99%

15-Year Change

-1289.99%

ZBIO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

26.37%
ZBIO annual cash from investing is higher than 26.37% of companies in Healthcare sector

Range

All-Time High

-$17.00K
ZBIO annual cash from investing is currently >-9900.00% below its historical high of -$17.00 thousand

3-Year Low

-$30.55M
ZBIO annual cash from investing is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ZBIO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 17, 2026
ZBIO next annual earnings announcement is scheduled for Mar 17, 2026

OtherZBIOcash flow metrics

Annual CFF

$412.96M
ZBIO annual cash from financing is $412.96 million

Annual CFO

-$119.67M
ZBIO annual cash from operations is -$119.67 million

Annual FCF

-$119.81M
ZBIO annual free cash flow is -$119.81 million

Annual CAPEX

$131.00K
ZBIO annual capital expenditures is $131.00 thousand

Quarterly CFI:

$40.04M+$152.33M(+135.66%)
September 30, 2025

Summary

  • As of today, ZBIO quarterly cash from investing is $40.04 million, with the most recent change of +$152.33 million (+135.66%) on September 30, 2025.
  • Over the past year, ZBIO quarterly cash from investing has increased by +$66.80 million (+249.64%).
  • ZBIO quarterly cash from investing is now at all-time high.

Performance

3-Month Change

+135.66%

1-Year Change

+249.64%

3-Year Change

-

5-Year Change

-

ZBIO Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

92.96%
ZBIO quarterly cash from investing is higher than 92.96% of companies in Healthcare sector

Range

All-Time High

$40.04M
ZBIO quarterly cash from investing is currently at an all-time high

3-Year Low

-$112.29M
ZBIO quarterly cash from investing is currently +135.66% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ZBIO previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 17, 2026
ZBIO next earnings announcement is scheduled for Mar 17, 2026

OtherZBIOcash flow metrics

Quarterly CFF

$72.62M
ZBIO quarterly cash from financing is $72.62 million

Quarterly CFO

-$41.13M
ZBIO quarterly cash from operations is -$41.13 million

Quarterly FCF

-$41.13M
ZBIO quarterly free cash flow is -$41.13 million

Quarterly CAPEX

$0.00
ZBIO quarterly capital expenditures is $0.00

TTM CFI:

-$162.26M+$66.80M(+29.16%)
September 30, 2025

Summary

  • As of today, ZBIO TTM cash from investing is -$162.26 million, with the most recent change of +$66.80 million (+29.16%) on September 30, 2025.
  • Over the past year, ZBIO TTM cash from investing has dropped by -$135.44 million (-505.05%).

Performance

3-Month Change

+29.16%

1-Year Change

-505.05%

3-Year Change

-

5-Year Change

-

ZBIO TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

12.21%
ZBIO TTM cash from investing is higher than 12.21% of companies in Healthcare sector

Range

All-Time High

$0.00
ZBIO TTM cash from investing is currently >-9900.00% below its historical high of $0.00

3-Year Low

-$229.06M
ZBIO TTM cash from investing is currently +29.16% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ZBIO previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 17, 2026
ZBIO next earnings announcement is scheduled for Mar 17, 2026

OtherZBIOcash flow metrics

TTM CFF

$76.29M
ZBIO TTM cash from financing is $76.29 million

TTM CFO

-$158.47M
ZBIO TTM cash from operations is -$158.47 million

TTM FCF

-$158.56M
ZBIO TTM free cash flow is -$158.56 million

TTM CAPEX

$92.00K
ZBIO TTM capital expenditures is $92.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ZBIO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-10000.0%+249.6%-505.1%
3Y3 Years-1290.0%--
5Y5 Years-1290.0%--

ZBIO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year>-9999.0%at lowat high+135.7%>-9999.0%+29.2%
5Y5-Year>-9999.0%at lowat high+135.7%>-9999.0%+29.2%
All-TimeAll-Time>-9999.0%at lowat high+135.7%>-9999.0%+29.2%

ZBIO Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
$40.04M(+135.7%)
-$162.26M(+29.2%)
Jun 2025
-
-$112.29M(-30.2%)
-$229.06M(-96.1%)
Mar 2025
-
-$86.27M(-2209.9%)
-$116.80M(-282.3%)
Dec 2024
-$30.55M
-$3.73M(+86.0%)
-$30.55M(-13.9%)
Sep 2024
-
-$26.76M(>-9900.0%)
-$26.82M(>-9900.0%)
Jun 2024
-
-$35.00K(-59.1%)
-$57.00K(-159.1%)
DateAnnualQuarterlyTTM
Mar 2024
-
-$22.00K(>-9900.0%)
-$22.00K(>-9900.0%)
Dec 2023
-$17.00K(+99.2%)
-
-
Sep 2023
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2023
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2023
-
$0.00
$0.00
Dec 2022
-$2.20M
-
-

FAQ

  • What is Zenas BioPharma, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Zenas BioPharma, Inc.?
  • What is Zenas BioPharma, Inc. annual cash from investing year-on-year change?
  • What is Zenas BioPharma, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Zenas BioPharma, Inc.?
  • What is Zenas BioPharma, Inc. quarterly cash from investing year-on-year change?
  • What is Zenas BioPharma, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Zenas BioPharma, Inc.?
  • What is Zenas BioPharma, Inc. TTM cash from investing year-on-year change?

What is Zenas BioPharma, Inc. annual cash from investing?

The current annual cash from investing of ZBIO is -$30.55M

What is the all-time high annual cash from investing for Zenas BioPharma, Inc.?

Zenas BioPharma, Inc. all-time high annual cash from investing is -$17.00K

What is Zenas BioPharma, Inc. annual cash from investing year-on-year change?

Over the past year, ZBIO annual cash from investing has changed by -$30.54M (-179617.65%)

What is Zenas BioPharma, Inc. quarterly cash from investing?

The current quarterly cash from investing of ZBIO is $40.04M

What is the all-time high quarterly cash from investing for Zenas BioPharma, Inc.?

Zenas BioPharma, Inc. all-time high quarterly cash from investing is $40.04M

What is Zenas BioPharma, Inc. quarterly cash from investing year-on-year change?

Over the past year, ZBIO quarterly cash from investing has changed by +$66.80M (+249.64%)

What is Zenas BioPharma, Inc. TTM cash from investing?

The current TTM cash from investing of ZBIO is -$162.26M

What is the all-time high TTM cash from investing for Zenas BioPharma, Inc.?

Zenas BioPharma, Inc. all-time high TTM cash from investing is $0.00

What is Zenas BioPharma, Inc. TTM cash from investing year-on-year change?

Over the past year, ZBIO TTM cash from investing has changed by -$135.44M (-505.05%)
On this page